Drug & supplement interaction

Active Hexose Correlated Compound (ahcc) + Ofatumumab

Ofatumumab brand name: Kesimpta.

Moderate Interaction
The bottom line Moderate

Active Hexose Correlated Compound (ahcc) has a moderate interaction with Ofatumumab. Theoretically, taking AHCC might decrease the effects of immunosuppressant drugs.

Read the full interaction report
SeverityModerate
LikelihoodPossible
EvidenceD
What do Severity, Likelihood & Evidence mean?
Know someone taking this? Share
Interaction report

Active Hexose Correlated Compound (ahcc) and Ofatumumab

Here is the interaction we found between these two, with the evidence behind it.

Moderate

IMMUNOSUPPRESSANTS

Why this applies to Ofatumumab

Ofatumumab falls under IMMUNOSUPPRESSANTS — the group Active Hexose Correlated Compound (ahcc) interacts with.

Theoretically, taking AHCC might decrease the effects of immunosuppressant drugs.
Data from human, animal, and in vitro studies suggests that AHCC stimulates immune function. Theoretically, this may counteract immunosuppressant drug activity.
Severity Moderate Likelihood Possible Evidence D

Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists.

Dr. Brian Staiger, PharmD, BCPS
Dr. Brian Staiger explains PharmD, Clinical Pharmacist

Here's the thinking behind this one. Ofatumumab (Kesimpta) works by calming down part of your immune system to reduce MS relapses. It targets and lowers certain B-cells that drive nerve inflammation. AHCC, on the other hand, is promoted to rev up immune activity, things like natural killer cells and other immune players. So in theory, the two could pull in opposite directions, and AHCC might blunt some of the benefit you're getting from your MS treatment.

I want to be honest though: this is a theoretical concern based on how each one works, not on real patient studies showing a problem. Ofatumumab isn't a prodrug, so nothing here changes how it's activated. Still, since your MS therapy matters a lot, please check with your neurologist or pharmacist before adding AHCC rather than starting or stopping anything on your own.

References
  1. Burikhanov, R. B., Wakame, K., Igarashi, Y., Wang, S., and Matsuzaki, S. Suppressive effect of active hexose correlated compound (AHCC) on thymic apoptosis induced by dexamethasone in the rat. Endocr.Regul. 2000;34(4):181-188.
  2. Gao, Y., Zhang, D., Sun, B., Fujii, H., Kosuna, K., and Yin, Z. Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses. Cancer Immunol.Immunother. 2006;55(10):1258-1266. PubMed
  3. Ritz, B. W., Nogusa, S., Ackerman, E. A., and Gardner, E. M. Supplementation with active hexose correlated compound increases the innate immune response of young mice to primary influenza infection. J Nutr. 2006;136(11):2868-2873. PubMed
  4. Aviles, H., O'Donnell, P., Sun, B., and Sonnenfeld, G. Active hexose correlated compound (AHCC) enhances resistance to infection in a mouse model of surgical wound infection. Surg.Infect.(Larchmt.) 2006;7(6):527-535. PubMed
  5. Aviles, H., O'Donnell, P., Orshal, J., Fujii, H., Sun, B., and Sonnenfeld, G. Active hexose correlated compound activates immune function to decrease bacterial load in a murine model of intramuscular infection. Am J Surg. 2008;195(4):537-545. PubMed
  6. Ritz, B. W. Supplementation with active hexose correlated compound increases survival following infectious challenge in mice. Nutr.Rev. 2008;66(9):526-531. PubMed
  7. Terakawa, N., Matsui, Y., Satoi, S., Yanagimoto, H., Takahashi, K., Yamamoto, T., Yamao, J., Takai, S., Kwon, A. H., and Kamiyama, Y. Immunological effect of active hexose correlated compound (AHCC) in healthy volunteers: a double-blind, placebo-controll
  8. Wang, S., Welte, T., Fang, H., Chang, G. J., Born, W. K., O'Brien, R. L., Sun, B., Fujii, H., Kosuna, K., and Wang, T. Oral administration of active hexose correlated compound enhances host resistance to West Nile encephalitis in mice. J Nutr. 2009;139(3 PubMed
  9. Yin, Z., Fujii, H., and Walshe, T. Effects of active hexose correlated compound on frequency of CD4+ and CD8+ T cells producing interferon-gamma and/or tumor necrosis factor-alpha in healthy adults. Hum.Immunol. 2010;71(12):1187-1190.
  10. Lee, W. W., Lee, N., Fujii, H., and Kang, I. Active Hexose Correlated Compound promotes T helper (Th) 17 and 1 cell responses via inducing IL-1beta production from monocytes in humans. Cell Immunol. 2012;275(1-2):19-23.
  11. Daddaoua, A., Martinez-Plata, E., Ortega-Gonzalez, M., Ocon, B., Aranda, C. J., Zarzuelo, A., Suarez, M. D., de Medina, F. S., and Martinez-Augustin, O. The nutritional supplement Active Hexose Correlated Compound (AHCC) has direct immunomodulatory actio
  12. Roman, B. E., Beli, E., Duriancik, D. M., and Gardner, E. M. Short-term supplementation with active hexose correlated compound improves the antibody response to influenza B vaccine. Nutr Res. 2013;33(1):12-17. PubMed
  13. Uno, K., Kosuna, K., Sun, B., Fujii, H., Wakame, K., Chikumaru, S., Hosokawa, G., and Ueda, Y. Active Hexose Correlated Compound (AHCC) Improves Immunological Parameters and Performance Status of Patients with Solid Tumors. Biotherapy 2000;14(3):303-309.
  14. Ghoneum, M., Wimbley, M., Salem, F., McKlain, A., Attallah, N., and Gill, G. Immunomodulatory and anticancer effects of active hexose correlated compound (AHCC). Int J Immunother 1995;11:23-28.

What These Ratings Mean

Every interaction above is graded three ways — here’s the key to each label.

Severity how clinically significant the interaction is
Major

Clinically significant. Avoid the combination, or use only under close professional supervision.

Moderate

Usually worth avoiding or managing — may need monitoring, a dose change, or timing apart.

Minor

Generally not serious. Be aware of it and mention it to your pharmacist.

Likelihood how strong the evidence is that the interaction actually happens in people
  • LikelyWell-controlled human studies have demonstrated the likely existence of this interaction.
  • ProbableInteraction has not been documented in well-controlled studies, however, the interaction has been demonstrated in some small human studies or in controlled animal studies in conjunction with multiple case reports.
  • PossibleInteraction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists.
  • UnlikelyInteraction has been demonstrated in animal or in lab research but has been shown not to occur in humans.
Evidence the quality of the studies behind the rating (graded A–D)
  • AHigh-quality meta-analysis (quantitative systematic review).
  • BCase-control study.
  • CConsensus.
  • DAnecdotal evidence.

These ratings are for information only. Never start, stop, or otherwise change your therapy before speaking with your provider.

Keep it in perspective

Active Hexose Correlated Compound (ahcc) Also Interacts With Other Medications

Active Hexose Correlated Compound (ahcc) has 311 moderate known drug interactions in our database — the Ofatumumab one above is one of them. If you take anything else, check it against the full list below.

Taking anything else?

Check Another of Your Medications Against Active Hexose Correlated Compound (ahcc)

Covers the 2,830 medications we’ve checked against Active Hexose Correlated Compound (ahcc). Pick one to open its full report.

Everything else you take

See Every Supplement That Interacts With Ofatumumab

This page covers Active Hexose Correlated Compound (ahcc) only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Ofatumumab page lists 53 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Alfalfa (moderate), American Ginseng (moderate), Andrographis (moderate), Ashwagandha (moderate) and Astragalus (moderate).

By severity: 52 moderate · 1 minor.

From our pharmacist’s overview on the Ofatumumab page

“Kesimpta (ofatumumab) treats multiple sclerosis by deliberately quieting part of the immune system, and all 53 supplements on this page raise the same worry from the opposite direction. Each is thought to stimulate immune activity, which could in theory blunt what the drug is trying to do.”

Reviewed by 2 · Jul 18, 2026

Open the Ofatumumab interaction page

How much people look this up

Where Active Hexose Correlated Compound (ahcc) and Ofatumumab Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Active Hexose Correlated Compound (ahcc)
Top half

#672 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Ofatumumab
Steady interest

#1,639 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Supplement

About Active Hexose Correlated Compound (ahcc)

What is Active Hexose Correlated Compound (ahcc)?

Active Hexose Correlated Compound (ahcc)
  • Immune support
  • Supporting people during chemotherapy
  • General wellness
  • Liver health
  • HPV-related concerns

AHCC is a proprietary mushroom-derived supplement promoted mainly for immune support and to help people tolerate cancer treatment. Early human studies are interesting but small, and the overall evidence is limited and not conclusive for any condition. Talk with your pharmacist or doctor before using it, especially if you have a health condition or take medications.

Read the full Active Hexose Correlated Compound (ahcc) monograph & all interactions
Medication

About Ofatumumab Injection (Multiple Sclerosis)

What Is Ofatumumab Injection (Multiple Sclerosis) Used For?

Brand name: Kesimpta

Kesimpta is used to treat relapsing forms of multiple sclerosis (MS) in adults. This includes clinically isolated syndrome (a first MS episode), relapsing-remitting MS (the most common form, with flares followed by recovery periods), and active secondary progressive MS (when the disease slowly worsens but still has active flares).

It is designed to reduce relapses and slow disease activity by targeting certain immune cells believed to drive MS damage.

See full Ofatumumab Injection (Multiple Sclerosis) drug information
Keep checking

Other Drugs & Active Hexose Correlated Compound (ahcc)

Browse every other medication we’ve checked against Active Hexose Correlated Compound (ahcc) — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
311Moderate
0Minor
2,518No known interaction
Moderate

311 interactions

Showing 60 of 311 moderate interactions — see all 311 on the Active Hexose Correlated Compound (ahcc) page.

No interaction 2,518 drugs checked — show the list

We also checked Active Hexose Correlated Compound (ahcc) against these medications and found no known interaction in our sources. Open any page to confirm.

Showing the 60 most looked-up of 2,518 medications checked with no known interaction — see the full Active Hexose Correlated Compound (ahcc) list.

Sources

Sources & How We Checked

Interaction details are evidence-graded and sourced from the Natural Medicines database. The medication overview comes from MedlinePlus.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring
Pharmacist Counseling Corner

Taking Active Hexose Correlated Compound (ahcc) and Ofatumumab Together: Common Questions

Can you take Active Hexose Correlated Compound (ahcc) with Ofatumumab?
There is a moderate interaction, so it may be acceptable with monitoring or timing changes — but check with your pharmacist first. Read the full details on this page and confirm with your pharmacist before combining them.
How serious is the Active Hexose Correlated Compound (ahcc) and Ofatumumab interaction?
We rate it Moderate. This combination may require monitoring, a dose adjustment, or separating the times you take each one. Consult your pharmacist before using them together.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Ofatumumab and Active Hexose Correlated Compound (ahcc)?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.